glp 1 blindness study A nurse lost her eyesight while on GLP-1 drugs. She said she did not know of the potential risk, which is listed on the packaging in Europe but not in the U.S Study: Ozempic linked to eye
Description
Lilly expects to receive FDA approval for orforglipron next quarter

Are not seeking aggressive appetite suppression

While taking the medication, many people notice: reduced hunger feeling full faster fewer cravings improved portion control more stable blood sugar levels After stopping semaglutide, appetite hormones gradually return toward baseline levels

Demand has been driven by social media influencers and celebrities, leading many people to use the drugs off-label, meaning for a condition other than that for which it has been officially approved
Nature Health , 2026

doi: 10.1111/dom.14005 71 RiddleMCAronsonRHomePMarreMNiemoellerEMiossecPet al
